In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing for a healthcare partner in Puerto Rico. By the end of November, CTS implements universal individual Zika testing on all blood donations in the US, due to an FDA requirement.
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...